Sort
40,608 grants matching “prostate cancer”
APT: the Analytical Proteomics Team
$1,164,358Fred E Regnier · Purdue University · U24 · FY2008 · CA
CORRELATING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION WITH MOLECULAR PROFILES IN PROSTATE CANCER
$1,164,294Cedars-Sinai Medical Center · · FY2025 · Defense Health Agency
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
$1,163,643Samuel E. Adunyah · Meharry Medical College · U54 · FY2025 · CA
Mouse Model of Cell Cycle Deregulation in Cancer
$1,163,374University Of Texas Md Anderson Can Ctr · U01 · FY2002 · ES
NCCU NCMHD RESEARCH CENTER OF EXCELLENCE
$1,163,274Kevin Sean Kimbro · North Carolina Central University · P20 · FY2011 · MD
SLC37A3 AS A NOVEL PROSTATE CANCER TARGET
$1,163,218Case Western Reserve University · · FY2024 · Defense Health Agency
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,162,978Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2016 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
$1,162,611Daniel B Vigneron · University Of California, San Francisco · R01 · FY2015 · EB
UCLA SPORE in Prostate Cancer
$1,162,609Robert E Reiter · University Of California Los Angeles · P50 · FY2018 · CA
Genomewide Association Study of Prostate Cancer
$1,162,562John S Witte · University Of California, San Francisco · U01 · FY2010 · CA
DEVELOPMENT AND PRECLINICAL EVALUATION OF A NOVEL TARGETED RADIONUCLIDE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER.
$1,162,500Purdue University · · FY2021 · Defense Health Agency
RACE, CYP27A1, AND ESTROGEN SIGNALING IN PROSTATE CANCER
$1,162,139Cedars-Sinai Medical Center · · FY2021 · Defense Health Agency
Targeting pancreatic cancer metastases with Targefrin
$1,162,000Carlo Baggio · Armida Labs, Inc. · R44 · FY2025 · CA
LEVERAGING SULT2B1B OXYSTEROL SULFOTRANSFERASE FOR INHIBITION OF CASTRATION RESISTANT PROSTATE CANCER
$1,161,253The University Of Texas Health Science Center At San Antonio · · FY2021 · Defense Health Agency
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,160,113Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Mouse Models of Prostate Cancer
$1,159,972Norman Michael Greenberg · Fred Hutchinson Cancer Research Center · U01 · FY2008 · CA
Tumor selective inhibition of the WNT pathway
$1,159,628Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Novel Markers for Disease Outcome in Breast Cancer
$1,159,062Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
METABOLISM AS THE ACHILLES HEEL IN PROSTATE CANCER
$1,158,750University Of Toledo · · FY2020 · Defense Health Agency
Center for Advanced Imaging Innovation and Research (CAI2R)
$1,158,678Daniel K Sodickson · New York University School Of Medicine · P41 · FY2016 · EB
Early Life Exposures and Subsequent Cancer Risk
$1,158,639Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Deep South CanCORS Colorectal and Lung Cancer PDCR Site
$1,158,466University Of Alabama At Birmingham · U01 · FY2002 · CA
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,158,050Elva M Arredondo · San Diego State University · U54 · FY2012 · CA
DRIVING NATURAL KILLER CELL IMMUNOTHERAPY IN THE CASTRATION-RESISTANT PROSTATE CANCER SETTING WITH NOVEL TRISPECIFIC KILLER ENGAGER MOLECULES
$1,157,718Regents Of The University Of Minnesota · · FY2020 · Defense Health Agency
Image Guided Therapy
$1,157,532Ferenc A Jolesz · Brigham And Women'S Hospital · P01 · FY2009 · CA